Ranbaxy Makes "Practical" Bid For Merck KGaA's Generics Unit
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy confirmed reports that it made a bid for Merck KGaA's generic drugs unit, but the Indian generics company maintained that the offer does not overvalue the Merck asset